U.S., May 16 -- ClinicalTrials.gov registry received information related to the study (NCT06416774) titled 'A Clinical Study of 68Ga-HX01 Injection for PET Imaging' on May 11.

Brief Summary: This is a single-center, open Phase I clinical study, consisting of two parts: a Phase Ia study in healthy adult subjects and a Phase Ib study in patients with malignant solid tumors.

Study Type: Interventional

Condition: * Healthy

* Malignancy

Intervention: * Drug: 68Ga-HX01 Injection(0.05mCi/kg)

The study is divided into three stages, including screening period, administration period and follow-up observation period. The maximum screening period is 7 days. Eligible subjects will receive intravenous injection of the experimental drug 68Ga-HX01 on...